Biosysen (HKG:1355) on Wednesday said it agreed to issue HK$50 million convertible bonds to Osibao Cosmetic International to settle amounts owed to the substantial shareholder, according to a filing with the Hong Kong bourse.
The bonds convert into 322.6 million shares of the company at an initial rate of HK$0.155 apiece. The shares represent 27.04% of the company's issued share capital and 21.28% as enlarged by the conversion.
The bonds will be interest-free, the firm said.
JK Tyre & Industries (NSE:JKTYRE, BOM:530007) reported an increase in attributable consolidated profit to 1.78 billion Indian rupees in the fiscal fourth quarter ended March 31, from 987.8 million rupees in the same period last year, according to a Tuesday filing on the Indian bourses.Earnings per share climbed to 6.25 rupees from 3.47 rupees a year earlier.Revenue from operations in fiscal Q4 increased year on year to 42.2 billion rupees from 37.6 billion rupees, the filing said.The board also recommended a dividend of 4 rupees per share for the financial year ended March 31.
Jiangsu Guofu Hydrogen Energy Equipment (HKG:2582) said its associated company Hydro Data was exploring expanding its business in Thailand and Southeast Asia with Charoen Energy and Water Asia Company, according to a Wednesday filing with the Hong Kong bourse.Under the comprehensive energy solutions agreement, CEWA will identify potential data center projects in the selected regions, while Hydro Data will provide customized technical plans and Guofu Hydrogen will supply relevant power generation equipment.The parties plan to cooperate on a pilot project in Rayong, Thailand, with a designated IT load capacity of 3 megawatts, which could later expand to 100 megawatts in total.
China Isotope & Radiation (HKG:1763) proposed appointing ShineWing Certified Public Accountants as its auditor for the financial year ending Dec. 31, according to a Wednesday Hong Kong bourse filing.Shinewing HK CPA, the company's current auditor, will not seek reappointment upon the expiration of its term at the conclusion of the company's 2025 annual general meeting.